- Human pathology

Home > G. Tumoral pathology > alveolar rhabdomyosarcoma

alveolar rhabdomyosarcoma

Tuesday 25 November 2003


- Alveolar rhabdomyosarcoma.

- ARMS : focal desmin w/ diffuse myogenin in A-RMS (PCR + PAX3-FOXO1)

- Compact ARMS : Alveolar rhabdomyosarcoma may lack alveolar spaces. Solid nodules uniform round cells,fibrous septa. DIFFUSE myogenin.

Digital slides

- Case 220 (HPC:220) : Alveolar rhabdomyosarcoma
- Case 215 (HPC:215) : Alveolar rhabdomyosarcoma, solid variant
- UI:879 - Alveolar rhabdomyosarcoma


- limbs
- orbit
- perineal region
- lungs
- skin (12131163)


- disseminated intravascular coagulation (DIVC)
- hyperfibrinolysis


- solid alveolar rhabdomyosarcoma (compact alveolar rhabdomyosarcoma) (8172322, 11280599)
- embryonal-like alveolar rhabdomyosarcoma with PAX3 rearrangement at 2q35 by t(2;20)(q35;p12) (15120913)
- multiple morphological alveolar rhabdomyosarcomas (17097083)

Cytogenetics and molecular biology

Cytogenetic and molecular studies have shown that approximately 80% of cases of alveolar rhabdomyosarcoma (ARMS) have consistent chromosomal translocation of either t(2;13) or t(1;13), resulting in either PAX3-FKHR or PAX7-FKHR gene fusions. However, 20% of the cases diagnosed histologically are negative for these fusion genes. The expression of PAX3-FOXO1A and PAX7-FOXO1A identifies a very high-risk subgroup (12039929)

- PAX3 rearrangements at 2q35 (PAX3 fusion genes)

- PAX7 rearrangements at 1p36 (PAX7 fusion genes)

- no fusion transcript detected in 20% of the cases (12183429, 12039929)

- other translocations decribed

- secondary translocations

Regional amplification

- 2p24 amplification (MYCN amplification) (9872655, 11063797)
- 13q31 amplification (10825007)
- 12q13-15 amplification

- amplification of the fusion genes


- CDKN2A/B in 9q21

Other chromosomal anomalies

- hypotetraploidy (10825007)
- isochromosome 1q (9809033)

Expression profiling: 9823299


- Nascent pre-rRNA overexpression correlates with an adverse prognosis in alveolar rhabdomyosarcoma (16770781)



See also

- rhabdomyosarcomas (RMSs)


- Mercado GE, Barr FG. Fusions involving PAX and FOX genes in the molecular pathogenesis of alveolar rhabdomyosarcoma: recent advances. Curr Mol Med. 2007 Feb;7(1):47-61. PMID: 17311532

- Barr FG. Gene fusions involving PAX and FOX family members in alveolar rhabdomyosarcoma. Oncogene. 2001 Sep 10;20(40):5736-46. PMID: 11607823


- Parham DM, Qualman SJ, Teot L, Barr FG, Morotti R, Sorensen PH, Triche TJ, Meyer WH; Soft Tissue Sarcoma Committee of the Children’s Oncology Group. Correlation between histology and PAX/FKHR fusion status in alveolar rhabdomyosarcoma: a report from the Children’s Oncology Group. Am J Surg Pathol. 2007 Jun;31(6):895-901. PMID: 17527077

- Williamson D, Lu YJ, Fang C, Pritchard-Jones K, Shipley J. Nascent pre-rRNA overexpression correlates with an adverse prognosis in alveolar rhabdomyosarcoma. Genes Chromosomes Cancer. 2006 Sep;45(9):839-45. PMID: 16770781

- Sorensen PH, Lynch JC, Qualman SJ, Tirabosco R, Lim JF, Maurer HM, Bridge JA, Crist WM, Triche TJ, Barr FG. PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: a report from the children’s oncology group. J Clin Oncol. 2002 Jun 1;20(11):2672-9. PMID: 12039929

- Taylor AC, Shu L, Danks MK, Poquette CA, Shetty S, Thayer MJ, Houghton PJ, Harris LC. P53 mutation and MDM2 amplification frequency in pediatric rhabdomyosarcoma tumors and cell lines. Med Pediatr Oncol. 2000 Aug;35(2):96-103. PMID: 10918230

- Khan J, Simon R, Bittner M, Chen Y, Leighton SB, Pohida T, Smith PD, Jiang Y, Gooden GC, Trent JM, Meltzer PS. Gene expression profiling of alveolar rhabdomyosarcoma with cDNA microarrays. Cancer Res. 1998 Nov 15;58(22):5009-13. PMID: 9823299

- Berner JM, Forus A, Elkahloun A, Meltzer PS, Fodstad O, Myklebost O. Separate amplified regions encompassing CDK4 and MDM2 in human sarcomas. Genes Chromosomes Cancer. 1996 Dec;17(4):254-9. PMID: 8946207